[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fa2hkwdIsj7W_5k6zzsph4XCznaKeONUdzMssGaEn0cU":8,"$feKXIPMCNwWLjmsa8K-oY_z6ODH1_N4-mnhZkebKL2pw":55,"$fkbZd9pNUS13r_HzdzKqNYDGd_35ggXokonecHyLEk_o":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65697,869175,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//nuLUzB4GAI2Ye2KfylUD1xt9kYOe29It.png","李雯","东港市中心医院","肿瘤科","主治医师",17,0,"直肠癌局晚期治疗常用药品使用指南","","https://ystcdn.venuertc.com/venue/AI/2469f316-87c3-41aa-8ea9-254d0ee7b228.jpg","\u003Cdiv class=\"material-container\">\n  \u003Ch2 id=\"material_title\" class=\"material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">直肠癌局晚期治疗常用药品使用指南\u003C/h2>\n  \u003Cdiv class=\"material-section material-intro\">\n    \u003Cdiv class=\"material-bg-light\">\n      \u003Cp>说到直肠癌治疗，大家最关心的，往往不是手术本身，而是药物怎么用才安全有效。无论你是在接受化疗、靶向治疗，还是辅助药物，掌握正确用药方法和安全细节，才是提高治疗效果、减少副作用的关键。本文将分7个板块，为你详细解析直肠癌局晚期治疗相关常用药品的实用使用要点和注意事项，每个环节都有具体指导，让你用药不留死角。🌱\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 剂型与规格：直肠癌局晚期常用药物特点分析\u003C/h2>\n    \u003Cdiv class=\"material-bg-image\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>化疗制剂：\u003C/strong>主要包括奥沙利铂（Oxaliplatin，注射液）和卡培他滨（Capecitabine，口服片剂/肠溶片）。奥沙利铂通常为50mg/100mg装，需静脉滴注；卡培他滨常见规格为150mg/500mg片剂。\u003C/li>\n        \u003Cli>\u003Cstrong>靶向治疗：\u003C/strong>如贝伐珠单抗（Bevacizumab，注射液），规格多为100mg/4ml或400mg/16ml，用于静脉输注。\u003C/li>\n        \u003Cli>\u003Cstrong>免疫治疗：\u003C/strong>帕博利珠单抗（Pembrolizumab，注射液），常见规格为100mg/4ml。\u003C/li>\n        \u003Cli>这些药品有明确的剂型，服用方法分别有严格的输液、口服或肠溶要求，不能随意互换。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 作用机制简介：药品如何发挥效应？\u003C/h2>\n    \u003Cdiv class=\"material-bg-image\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>奥沙利铂：\u003C/strong>通过与DNA结合，阻断其复制，从而抑制肿瘤细胞增殖 \u003Cspan class=\"material-emoji\">🧬\u003C/span>。\u003C/li>\n        \u003Cli>\u003Cstrong>卡培他滨：\u003C/strong>是一种前体药物，在体内转化成氟尿嘧啶（5-FU），干扰DNA和RNA合成，起到抑制肿瘤细胞的作用（Van Cutsem et al., 2001）。\u003C/li>\n        \u003Cli>\u003Cstrong>贝伐珠单抗：\u003C/strong>通过阻断血管内皮生长因子（VEGF），减少病灶区域新生血管生成，限制肿瘤营养供给。\u003C/li>\n        \u003Cli>\u003Cstrong>帕博利珠单抗：\u003C/strong>属PD-1抑制剂，激活免疫系统识别并清除异常细胞（Robert et al., 2015）。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 用法用量详解：如何正确使用这些药品？\u003C/h2>\n    \u003Cdiv class=\"material-bg-image\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>奥沙利铂：\u003C/strong>静脉点滴，常规每三周一次，剂量按体表面积计算，不得自行调整。必须提前检查肾功能与过敏史。\u003C/li>\n        \u003Cli>\u003Cstrong>卡培他滨：\u003C/strong>口服，饭后30分钟用温水整片吞服，服用周期通常为两周服药、一周休息，每日分两次，剂量需由医生根据体重和耐受性调整。\u003C/li>\n        \u003Cli>\u003Cstrong>贝伐珠单抗：\u003C/strong>仅用于静脉输注，不可肌注或口服；首次输注速度较慢，后续可加快。每两周或三周一次，具体计量需遵医嘱。\u003C/li>\n        \u003Cli>\u003Cstrong>帕博利珠单抗：\u003C/strong>静脉点滴，每三周一次，固定剂量给药。儿童及老年人剂量调节需遵专科指引。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：均需严格按照医师处方使用，擅自更改剂量或间隔时间存在安全风险。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 服药流程与饮食搭配：用药细节实操指南\u003C/h2>\n    \u003Cdiv class=\"material-bg-image\">\n      \u003Cul>\n        \u003Cli>口服药（如卡培他滨）要求饭后30分钟整片吞服，不可嚼碎或掰断，以减少胃肠刺激与吸收影响。\u003C/li>\n        \u003Cli>化疗和靶向药（如奥沙利铂、贝伐珠单抗）输注期间全程监控，避免与大型高蛋白饮食同服。\u003C/li>\n        \u003Cli>服药期间要保证充足饮水（每天至少1500ml），有助于药物的排泄和降低肾毒性。\u003C/li>\n        \u003Cli>若出现吞咽困难，请告知医生，由药师予以剂型调整。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-tips-block\">\n        \u003Cstrong>特别提醒：\u003C/strong>肠溶片剂（如卡培他滨）必须整片吞服，切勿掰碎、嚼服，以免破坏药物包衣导致吸收异常。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用与联合用药规范\u003C/h2>\n    \u003Cdiv class=\"material-bg-image\">\n      \u003Cul>\n        \u003Cli>化疗药（如奥沙利铂）与其他肾毒性药物（如庆大霉素、阿米卡星）同时使用，会加重肾损伤风险。\u003C/li>\n        \u003Cli>卡培他滨与抗凝药（如华法林）同时使用时，易导致出血风险增加，必须密切监测凝血功能。\u003C/li>\n        \u003Cli>贝伐珠单抗不宜与高蛋白血浆制剂同用，以减少高血压等副作用。\u003C/li>\n        \u003Cli>免疫抑制剂（如帕博利珠单抗）不宜与激素长期联用，否则可能影响药效。\u003C/li>\n        \u003Cli>部分中草药（如灵芝、丹参）可能影响化疗药物代谢，需谨慎同时使用，请务必咨询药师。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正确做法：联合用药每种药都要查明说明书禁忌，必要时药师协助审核。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 用药禁忌与特殊人群调整\u003C/h2>\n    \u003Cdiv class=\"material-bg-image\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>奥沙利铂：\u003C/strong>有严重肾功能损害、已知过敏者禁止使用。孕妇及哺乳期妇女禁用。\u003C/li>\n        \u003Cli>\u003Cstrong>卡培他滨：\u003C/strong>葡萄糖-6-磷酸脱氢酶缺乏症、肝肾功能重度不全者禁用。孕期和哺乳期严禁使用。\u003C/li>\n        \u003Cli>\u003Cstrong>贝伐珠单抗：\u003C/strong>出血风险高者、未控制性高血压、近期外科手术者不可用。\u003C/li>\n        \u003Cli>\u003Cstrong>帕博利珠单抗：\u003C/strong>免疫相关疾病者需慎用，婴幼儿及孕期妇女目前尚无安全数据。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-tips-block\">\n        \u003Cstrong>需要注意：\u003C/strong>老年患者或肝肾功能轻度受损者，用药剂量需个体化调整，具体方案由专病医生决定。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 常见不良反应与处理策略\u003C/h2>\n    \u003Cdiv class=\"material-bg-image\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>奥沙利铂：\u003C/strong>易致手脚麻木、寒冷加重时明显，发生率约48%，严重者可停药或调整剂量（de Gramont et al., 2000）。\u003C/li>\n        \u003Cli>\u003Cstrong>卡培他滨：\u003C/strong>最常见为手足综合征及胃肠道反应（如腹泻、食欲下降），出现皮肤红肿脱皮时需就医。\u003C/li>\n        \u003Cli>\u003Cstrong>贝伐珠单抗：\u003C/strong>可能导致高血压、蛋白尿、鼻出血，长期使用监测血压及尿常规。\u003C/li>\n        \u003Cli>\u003Cstrong>帕博利珠单抗：\u003C/strong>少数人会有免疫相关皮疹、肠炎或甲状腺功能异常。\u003C/li>\n      \u003C/ul>\n      \u003Cp>出现副作用时，正确做法是及时与医生和药师沟通，绝不可擅自停药。严重反应如呼吸困难、剧烈腹泻等，需迅速就医。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 剂量遗漏与过量服用处理方法\u003C/h2>\n    \u003Cdiv class=\"material-bg-image\">\n      \u003Cul>\n        \u003Cli>如漏服口服化疗药（卡培他滨），可立即补服一次，若接近下次服药时间则跳过，无需重复剂量。\u003C/li>\n        \u003Cli>误多服时，不要随意催吐，可立即联系医生或药师，根据药物类型选择是否洗胃或支持治疗。\u003C/li>\n        \u003Cli>静脉药静点无特殊补救措施，一旦过量可能出现急性中毒，需专科紧急处理。\u003C/li>\n        \u003Cli>不论剂型，连续漏服或过量都要报告医师，由医师决定是否暂停或调整后续方案。\u003C/li>\n        \u003Cli>\u003Cstrong>正确做法：\u003C/strong>严格遵医嘱，坚持记录每次服药时间，防止药物间隔不均、剂量偏差。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 储存方法和药品管理\u003C/h2>\n    \u003Cdiv class=\"material-bg-image\">\n      \u003Cul>\n        \u003Cli>所有药品需密闭、避光、防潮保存。大多数复方制剂和注射液建议2-8°C冷藏。\u003C/li>\n        \u003Cli>口服药品开封后应放置于原包装盒内，远离儿童与宠物，防止误食。\u003C/li>\n        \u003Cli>静脉制剂取药后不宜长时间暴露空气，应在2小时内用完。\u003C/li>\n        \u003Cli>药品过期或变色、变形应立即弃置，切勿继续服用。\u003C/li>\n      \u003C/ul>\n      \u003Cp>保存得当可大幅降低药效流失风险，安全用药从规范管理做起。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 用药真实案例分享 🌼\u003C/h2>\n    \u003Cdiv class=\"material-bg-image\">\n      \u003Cul>\n        \u003Cli>有位57岁男性，接受奥沙利铂静点及卡培他滨口服联合用药，通过与医生精确沟通，每次点滴都严格按规范实施，未出现严重副作用。\u003C/li>\n        \u003Cli>临床使用贝伐珠单抗时，因患者高血压，团队提前优化降压方案，避免了用药风险。\u003C/li>\n        \u003Cli>老年患者调整帕博利珠单抗剂量后，免疫副作用显著减少，用药体验良好。\u003C/li>\n      \u003C/ul>\n      \u003Cp>药品安全用药，细节决定成败，每位患者都应从真实用药中汲取经验。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-summary\">\n    \u003Cdiv class=\"material-bg-light\">\n      \u003Cp>总结来看，直肠癌局晚期治疗的化疗、靶向和免疫药物，每一种都要求规范剂型选择、精准用法用量、恰当搭配及事故应对。\u003Cspan class=\"material-emoji\">🔑\u003C/span>特别需要记住：肠溶片不可嚼碎，过敏和肝肾功能要严格把关，不适当联合用药可能出现严重风险。遇到用药问题，随时咨询医生和专业药师，保障疗效和安全。\u003C/p>\n      \u003Cp>合理用药不是一句空话，而是一套严密的流程。希望本指南能为你和家人安全服药、减少副作用保驾护航。\u003C/p>\n      \u003Cdiv class=\"material-ref-block\">\n        \u003Ch3 class=\"material-subref\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献（APA格式）：\u003C/h3>\n        \u003Cul>\n          \u003Cli>Van Cutsem, E., Hoff, P.M., Harper, P., et al. (2001). \"Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study\". Journal of Clinical Oncology, 19(21), 4097–4106.\u003C/li>\n          \u003Cli>de Gramont, A., Figer, A., Seymour, M., et al. (2000). \"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer\". Journal of Clinical Oncology, 18(16), 2938–2947.\u003C/li>\n          \u003Cli>Robert, C., Long, G.V., Brady, B., et al. (2015). \"Nivolumab in previously untreated melanoma without BRAF mutation\". New England Journal of Medicine, 372(4), 320–330.\u003C/li>\n        \u003C/ul>\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-container {\n  font-family: \"Segoe UI\", \"Helvetica Neue\", Arial, sans-serif;\n  background: #fbfbfa;\n  padding: 32px 24px;\n  color: #252525;\n  max-width: 915px;\n  margin: 38px auto 40px auto;\n  border-radius: 16px;\n  box-shadow: 0 2px 18px rgba(120, 120, 120, 0.07);\n}\n.material-title {\n  text-align: center;\n  font-size: 38px;\n  font-weight: bold;\n  margin-bottom: 38px;\n  color: #1e5245;\n  letter-spacing: 1.4px;\n}\n.material-section {\n  margin-bottom: 38px;\n}\n.material-subtitle {\n  font-size: 28px;\n  font-weight: bold;\n  color: #255a8b;\n  letter-spacing: 0.8px;\n  margin-top: 26px;\n  margin-bottom: 18px;\n  padding: 8px 16px;\n  background: linear-gradient(90deg,#f8fbfc 60%, #eaf1fa 100%);\n  border-radius: 6px;\n  /* background-image design for subtitle */\n  border-left: 5px solid #60a7db;\n  box-shadow: 0 2px 12px rgba(80, 171, 219, 0.05);\n}\n.material-bg-light {\n  background: linear-gradient(135deg,#f5fbf7 80%,#eaf1fa 100%);\n  border-radius: 10px;\n  padding: 24px 26px;\n  margin-bottom: 6px;\n  box-shadow: 0 2px 12px rgba(194,212,217,0.07);\n}\n.material-bg-image {\n  background: linear-gradient(90deg,#f8fafa 93%, #f0f7fb 100%);\n  border-radius: 10px;\n  padding: 24px 28px;\n  margin-bottom: 6px;\n  box-shadow: 0 2px 11px rgba(150,170,210,0.05);\n  position: relative;\n}\n.material-bg-image:before {\n  content: '';\n  display: block;\n  position: absolute;\n  top: 0; left: 0;\n  width: 100%; height: 100%;\n  background: url('data:image/svg+xml;utf8,\u003Csvg width=\"200\" height=\"60\" xmlns=\"http://www.w3.org/2000/svg\">\u003Crect width=\"200\" height=\"60\" rx=\"16\" fill=\"%23eaf6fa\" opacity=\"0.18\"/>\u003Ccircle cx=\"60\" cy=\"30\" r=\"17\" fill=\"%23a4d3dc\" opacity=\"0.07\"/>\u003C/svg>');\n  opacity: 1;\n  z-index: 0;\n  pointer-events: none;\n}\n.material-bg-image ul,\n.material-bg-image p, \n.material-bg-image .material-tips-block,\n.material-bg-image div {\n  position: relative;\n  z-index: 1;\n}\n.material-tips-block {\n  background: #f6ede8;\n  border-left: 4px solid #d5780a;\n  color: #6b3505;\n  padding: 10px 18px;\n  margin: 17px 0 0 0;\n  border-radius: 6px;\n  font-size: 18px;\n}\n.material-summary {\n  margin-bottom: 0;\n}\n.material-ref-block {\n  padding: 16px 21px;\n  background: linear-gradient(135deg,#eaf5fc 90%, #f8fbfa 100%);\n  border-radius: 8px;\n  margin-top: 26px;\n  font-size: 18px;\n  color: #17425c;\n}\n.material-subref {\n  font-size: 22px;\n  font-weight: bold;\n  color: #255a8b;\n  margin-bottom: 8px;\n}\n.material-emoji {\n  font-size: 1.2em;\n  margin: 0 2px;\n}\n.material-section ul {\n  margin-top: 2px;\n  margin-bottom: 10px;\n  padding-left: 22px;\n}\n.material-section ul li {\n  font-size: 19px;\n  line-height: 1.82;\n  margin-bottom: 4px;\n  word-break: break-word;\n}\n.material-bg-image ul li {\n  font-size: 19px;\n}\n.material-section p {\n  font-size: 18px;\n  line-height: 1.8;\n  color: #444;\n  margin: 8px 0 0 0;\n}\n@media screen and (max-width: 700px) {\n  .material-container {\n    padding: 9vw 3vw;\n    max-width: 98vw;\n  }\n  .material-title {\n    font-size: 22px;\n    margin-bottom: 22px;\n  }\n  .material-subtitle {\n    font-size: 18px;\n    margin-top: 15px;\n    margin-bottom: 11px;\n    padding: 5px 7px;\n  }\n  .material-bg-image, .material-bg-light {\n    padding: 8vw 5vw;\n  }\n  .material-ref-block {\n    font-size: 14px;\n    padding: 6vw 4vw;\n  }\n  .material-section ul li,\n  .material-section p {\n    font-size: 15px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"material-container\">\n  \u003Ch2 id=\"material_title\" class=\"material-title\" style=\"color: rgb(",522,"2025-09-04 15:15:34","直肠癌, 化疗, 靶向治疗, 免疫治疗, 药品使用指南, 副作用, 安全用药, 患者护理","本文提供直肠癌局晚期化疗、靶向与免疫药物的详细使用指南，帮助患者安全用药、减少副作用，确保治疗效果。","2025-09-08 11:12:08",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]